Metabolic Therapies and Longevity: Beyond Disease Management

Exploring the longevity implications of metabolic therapies — from SGLT2 inhibitors and GLP-1 receptor agonists to dual agonists — examining cardiovascular outcomes, anti-inflammatory effects, and the evolving evidence base for metabolic interventions in healthy ageing.